Treatment and Prevention of Infection by Bd in two species of mountain yellow-legged frogs

The summary for the Treatment and Prevention of Infection by Bd in two species of mountain yellow-legged frogs grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Fish and Wildlife Service, which is the U.S. government agency offering this grant.

Treatment and Prevention of Infection by Bd in two species of mountain yellow-legged frogs: The study requires University of California, Santa Barbara staff to: 1) Visit two-thirds (14-16) of the R. sierrae and R. muscosa populations in the Sierra Nevada that remain Bd-nave to confirm disease status, 2) capture, PIT tag, swab, and treat up to 500 adult frogs from the affected sites, then release infected frogs post-treatment back into the sites from which they were collected, and 3) if conditions in certain populations warrant it, collection of some early life stages for transportation to a zoo for captive rearing. These frogs would be raised to adulthood, infected with Bd to immunize them, cleared of infection, and then reintroduced into the population from which they were collected. This award is made under the authority of: Endangered Species Act of 1973 et. seq. as amended.